Synthetic Design Lab focuses on advanced technologies that leverage synthetic biology to create innovative solutions across various industries. Their core offerings include tools and platforms that enable the design, construction, and optimization of biological systems. By utilizing cutting-edge techniques in genetic engineering and computational biology, the company aims to streamline the development of synthetic organisms and bio-based products, enhancing efficiency and sustainability in fields such as agriculture, pharmaceuticals, and environmental management.

The company emphasizes the integration of machine learning and data analytics into their synthetic biology processes. This approach allows for the rapid analysis of biological data, facilitating the identification of optimal genetic configurations and pathways. Additionally, Synthetic Design Lab is committed to fostering collaboration within the scientific community, promoting open-source methodologies and sharing knowledge to accelerate advancements in synthetic biology. Their focus on innovation and collaboration positions them as a leader in the field, driving the future of bioengineering and sustainable solutions.

United States

Synthetic Design Lab is built to revolutionize antibody-drug conjugates (ADCs) with its novel SYNTHBODY™ therapeutic platform. The platform is engineered to optimize targeted payload delivery ≥10x compared to current ADCs, potentially improving upon the efficacy, safety, and overall versatility of earlier ADCs.

Synthetic Design Lab

Company Details